Ming‐Liang Jin

674 citations
6 papers · 418 indexed · 1 hit paper · h-index 4
Topics
Cancer Risks and Factors (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)Metabolomics and Mass Spectrometry Studies (1 paper)
Partner nations
ChinaFranceUnited States

In The Last Decade

Ming‐Liang Jin

5 papers receiving 415 citations

Hit Papers

Metabolic-Pathway-Based Subtyping of Triple-Negative Brea...2020202620222024202050100150200250

Peers

Ming‐Liang Jin
Comparison fields: 5 of 65
  • Molecular Biology 237
  • Cancer Research 180
  • Oncology 157
  • Pulmonary and Respiratory Medicine 86
  • Immunology 69
Replace Wen-Jun Chai with:
Wen-Jun Chai China
Tieying Dong China
Shuchen Dong China
Jing Cui China
Lufeng Zhao China
Lijian Huang China
Martin H. Pedersen Denmark
Laura Steel United States
Ming‐Liang Jin relative to Wen-Jun Chai China Wen-Jun Chai's profile →
Citations per field
00.5×1.5×
Wen-Jun Chai · 1×
Citations per year

Countries citing papers authored by Ming‐Liang Jin

Since Specialization
Citations

This map shows the geographic impact of Ming‐Liang Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Liang Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Liang Jin more than expected).

Fields of papers citing papers by Ming‐Liang Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Liang Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Liang Jin. The network helps show where Ming‐Liang Jin may publish in the future.

Co-authorship network of co-authors of Ming‐Liang Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Liang Jin. A scholar is included among the top collaborators of Ming‐Liang Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Liang Jin. Ming‐Liang Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 0
2 6
3 56
4 59
5
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targetsbreakdown →
296
6 1

About Ming‐Liang Jin

Ming‐Liang Jin is a scholar working on Cancer Research, Oncology and Immunology, having authored 6 papers that have together received 418 indexed citations. Recurring topics across this work include Cancer Risks and Factors (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Metabolomics and Mass Spectrometry Studies (1 paper). The work is most often cited by research in Cancer Research (180 citations), Oncology (157 citations) and Molecular Biology (237 citations). Ming‐Liang Jin has collaborated with scholars based in China, France and United States. Frequent co-authors include Yue Gong, Peng Ji, Yu‐Chen Pei, Wen-Jun Chai, Linwei Guo, Yi‐Zhou Jiang, Xin Hu, Ding Ma, François Bertucci and Yi Xiao. Their work appears in journals such as Cell Metabolism, Cancer Research and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026